Patent Assignment
Reel/Frame 023973/0415
Release of Security Interest
Recorded: 2010-02-23
Pages: 28
Assignor
PHARMING GROUP N.V.
Executed: 2007-10-18
Assignee
KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
174 ROUTE DE LONGWY, LUXEMBOURG, L-1940, LUXEMBOURG
Covered Properties
(13)
Multiplying Bovine Embryos
Patent:
4,994,384 →
Application:
07/113,791 →
Dna Sequences to Target Proteins to the Mammary Gland for Efficient Secretion
Patent:
5,304,489 →
Application:
07/602,066 →
Parthenogenic Oocyte Activation
Patent:
5,496,720 →
Application:
08/016,703 →
Method of Cloning Bovine Embryos
Patent:
5,453,366 →
Application:
08/031,815 →
Method of Producing a Transgenic Bovine or Transgenic Bovine Embryo
Patent:
5,633,076 →
Application:
08/154,019 →
Targeted Synthesis of Protein in Mammary Gland of a Non-Human Transgenic Mammal
Patent:
5,994,616 →
Application:
08/186,836 →
Transgenic Animals Secreting Desired Proteins into Milk
Patent:
6,727,405 →
Application:
08/246,259 →
Parthenogenic Bovine Oocyte Activation
Patent:
5,843,754 →
Application:
08/473,794 →
Parthenogenic Oocyte Activation
Patent:
6,194,202 →
Application:
08/610,744 →
Parthenogenic Oocyte Activation
Patent:
6,077,710 →
Application:
09/176,395 →
Method of Cloning Bovines Using Reprogrammed Non-Embryonic Bovine Cells
Patent:
6,011,197 →
Application:
09/239,922 →
Method of Producing a Polypeptide in an Ungulate
Patent:
6,395,958 →
Application:
09/354,276 →
In Vitro Activation of Mammalian Oocytes
Patent:
6,680,199 →
Application:
09/576,592 →
Related Assignments
(14)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Feb 24, 2010
From: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
To: PHARMING INTELLECTUAL PROPERTY B.V
Reel/Frame 023985/0253 →
Release of Security Interest
Feb 24, 2010
From: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
To: PHARMING INTELLECTUAL PROPERTY B.V.
Reel/Frame 023985/0225 →
Assignment of Assignor's Interest
Mar 24, 2011
From: INTEGRATED GENETICS, INC.
To: GENZYME CORPORATION
Reel/Frame 026013/0581 →
Assignment of Assignor's Interest
Mar 24, 2011
From: GORDON, KATHERINE; GROET, SUZANNE
To: INTEGRATED GENETICS, INC.
Reel/Frame 026013/0512 →
Security Agreement
Jan 25, 2013
From: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
To: CAMOFI MASTER LDC; CAMHZN MASTER LDC
Reel/Frame 029698/0001 →
Release of Security Interest
Mar 11, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032424/0230 →
Release of Security Interest
Mar 14, 2014
From: LFB BIOTECHNOLOGIES S.A.S.U.
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032448/0045 →
Release of Security Interest
Nov 24, 2014
From: CAMOFI MASTER LDC; CAMHZN MASTER LDC
To: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
Reel/Frame 034421/0863 →
Security Interest
Dec 7, 2016
From: PHARMING GROUP N.V.
To: SILICON VALLEY BANK
Reel/Frame 040594/0031 →
Security Interest
Dec 7, 2016
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: SILICON VALLEY BANK
Reel/Frame 040839/0865 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0139 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0151 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING GROUP N.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0051 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →